About MDA Resources Donate Contact Us Book Store Ask A Question Site Index
I need Information for...
Patients, family and friends Medical Professionals Donors and Volunteers Researchers and institute
What is AMD
Encyclopedia
Glossary
Newsletter
News
Blogs
Donate
Helping Hands
Clinical Trials
Find It Fast
What is AMD
Director's Greeting
About MDA
Glossary
Newsletter
Blogs
News
Helping Hands
Therapy
Experiments
Nutrition
Research
Clinical Trials
Donate
Contact Us
Join the Discussion
Ask questions, exchange ideas, share stories
In the News

Summer Eye-Care Tips: How to Protect Your Peepers !

With September upon us, it may be hard to remember that we still need to use sun protection. With temperatures still summer-like, you still need to protect yourself, your skin, and even your eyes from the harmful rays of the sun.
read more>>
check for news>>
Treatments and Experiments

Limited Retinal Translocation for Wet Macular Degeneration

Limited Retinal Translocation-Limited retinal translocation is another treatment aimed at wet macular degeneration.
read more>>
check for treatments>>
Brought to you by Feedzilla
Research Programs

Federal stem cell ruling blocks Yale scientists

For two decades, Lawrence Rizzolo, the director of medical studies at the Yale School of Medicine, has been working toward a project that aims to transplant young, healthy retinal cells to replace diseased tissues in the eyes of patients who are going blind.
read more>

check for research>>
Nutrition

Nutrition is Closely Interrelated to Preventive Eye Care

The eye performs the function of sensing light and transmitting the signals through the optic nerves to the brain.
read more>>

check for nutrition>>
Helping Hands

Triathlon benefits eye research

Swim 800 meters, bike 18.5 miles and run four miles. To add to those already intimidating numbers, competition and speed are also factors.
read more>>

check for events>>
Therapy

FDA grants pSivida, Alimera expedited review for macular degeneration therapy

The Food & Drug Administration put pSivida Corp. (NSDQ:PSDV) and Alimera Sciences Inc. (NSDQ:ALIM) on the fast track, granting an expedited review for their drug/device combination designed to treat diabetic macular edema.
read more>>

check for therapy>>
Recent News
Powered By
widgetmate.com
Sponsored By
Digital Camera
Help  |  About the MDA  |  Employment & Volunteer Opportunities  |  Legal & Privacy Information
Submit Your Site To The Web's Top 50 Search Engines for Free!
The Macular Degeneration Association, a program of the American Medical Research Organization, is responsible for the content of the website www.maculardegenerationassociation.org . Its purpose is to provide useful information for persons with macular degeneration, their families, and the general public. This information is neither intended nor implied to be a substitute for professional medical advice relative to your specific medical condition or question. Always seek the advice of your physician or other health care provider for any questions you may have regarding your medical condition. Only your physician can provide specific diagnoses and treatments. The American Medical research Organization is recognized by the IRS as a 501 (c) (3) a tax exempt organization. The mission of the organization is to support research to help find a cure for macular degeneration and to improve the lives of all people affected by this disease. All content and works posted on this website are owned and copyrighted by the Macular Degeneration Association. All rights reserved. Copyright 2010 © American Medical Research Organization. All rights reserved.